Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Secukinumab leads to shifts from stage-based towards response-based disease clusters—comparative data from very early and established psoriatic arthritis

Fig. 1

Effects of secukinumab on patient-related outcomes in patients with very early and established psoriatic arthritis. Changes from baseline values adjusted for baseline values of each scale, gender, age and disease duration, and plotted as model coefficients and respective 95% confidence intervals that represent adjusted mean absolute improvement from baseline. DLQI, Dermatology Life Quality Index; HAQ, Health Assessment Questionnaire; PsA, psoriatic arthritis; PsAID, Psoriatic Arthritis Impact Of Disease; VAS, visual analog scale

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us